Insider · CIK 0001871355
Gavin M. O'Connor
officer
Files at XPOF (Xponential Fitness, Inc.), EWCZ (European Wax Center, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | XPOF Xponential Fitness, Inc. | AGrant or award Class A Common Stock | +137,851 | $0.00 | $0 | 137,851 | Nov 26, 2025 |
| Mar 14, 2025 | EWCZ European Wax Center, Inc. | FTax withholding Class A Common Stock | -1,865 | $4.35 | $8,113 | 133,075 | Mar 18, 2025 |
| Mar 7, 2025 | EWCZ European Wax Center, Inc. | FTax withholding Class A Common Stock | -2,997 | $5.55 | $17k | 134,940 | Mar 11, 2025 |
| Feb 16, 2025 | EWCZ European Wax Center, Inc. | FTax withholding Class A Common Stock | -913 | $7.35 | $6,711 | 137,937 | Feb 20, 2025 |
| Dec 8, 2024 | EWCZ European Wax Center, Inc. | AGrant or award Class A Common Stock | +75,000 | $0.00 | $0 | 138,850 | Dec 11, 2024 |
| Dec 8, 2024 | EWCZ European Wax Center, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Dec 11, 2024 |
| Dec 8, 2024 | EWCZ European Wax Center, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +42,500 | $0.00 | $0 | 42,500 | Dec 11, 2024 |
| Dec 8, 2024 | EWCZ European Wax Center, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +42,500 | $0.00 | $0 | 42,500 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.